Wild's post on iHub about an email response from L
Post# of 72440
Hi
Wow. How did that rumor come about! Mr. Evans and CTIX parted ways many years ago. He has no involvement in CTIX nor have we communicated with him in many years.
Concerning item 1, we had a successful end of Phase 2 meeting and we did receive the official word. That was announced in a PR. I also stated in a recent PR "In addition to advancing Kevetrin, the designing of the Phase 3 ABSSSI trial of Brilacidin is ongoing".
Best,
Leo Ehrlich | CEO |
You gotta give credit to the creativity of BS over there. Leo's email CC'ed to Geroge Evans. Bazinga!